Scientists test re-engineered immune cells to fight deadly brain cancer
NCT ID NCT05353530
Summary
This is an early-stage safety study testing a new type of personalized cell therapy for aggressive brain tumors in adults and children. Doctors take a patient's own immune cells, modify them in a lab to better target and attack cancer cells that have a specific marker called CD70, and then infuse them back into the patient. The main goals are to see if this process is safe and possible to do for patients with glioblastoma and other high-grade gliomas.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Florida Health
Gainesville, Florida, 32608, United States
Conditions
Explore the condition pages connected to this study.